Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. Mar Roca-Rodriguez"'
Autor:
Isabel Moreno-Indias, M. Mar Roca-Rodriguez, Leticia Coin-Aranguez, Isabel Mancha-Doblas, Gracia María Martin-Nuñez, Isabel Cornejo-Pareja, Francisco J. Tinahones, Fernando Cardona-Diaz
Publikováno v:
Diabetes. 68
Introduction: Antibiotic treatments modify gut microbiota. Microbiota alterations (in composition and biodiversity) are fundamental pieces in the development of metabolic disorders (T2DM and obesity). Objective: To evaluate the relationship between m
Autor:
Lidia Sánchez-Alcoholado, Isabel Cornejo-Pareja, Francisco J. Tinahones, José Carlos Fernández-García, Gracia María Martín-Núñez, Araceli Muñoz-Garach, Isabel Moreno-Indias, Fernando Cardona, Carolina Gutiérrez-Repiso, M. Mar Roca-Rodriguez, Leticia Coín-Aragüez
Publikováno v:
Journal of Clinical Medicine
Volume 8
Issue 4
Journal of Clinical Medicine, Vol 8, Iss 4, p 451 (2019)
Volume 8
Issue 4
Journal of Clinical Medicine, Vol 8, Iss 4, p 451 (2019)
Changes in the intestinal microbial community and some metabolic disturbances, including obesity and type2 diabetes, are related. Glucagon-like peptide-1 (GLP-1) regulates glucose homeostasis. Microbiota have been linked to incretin secretion. Antibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e508e5d01f28e56648249682470a8b4
https://hdl.handle.net/10668/13833
https://hdl.handle.net/10668/13833
Autor:
Laura Vinuela, Isabel Moreno-Indias, Gracia María Martín-Núñez, M. Mar Roca-Rodriguez, Isabel Mancha-Doblas, Isabel Cornejo-Pareja, Francisco J. Tinahones, Leticia Coin-Aranguez
Publikováno v:
Diabetes. 67
Introduction: Antibiotic treatments cause changes in gut microbiota. Dysbiosis of gut microbiota has been linked to metabolic diseases such as type 2 diabetes mellitus (T2DM). Objective: To evaluate whether changes in gut microbiota due to antibiotic
Autor:
Carmen Hernandez-Garcia, Araceli Muñoz-Garach, M. Mar Roca-Rodriguez, María Molina-Vega, Laura Vinuela-Gonzalez, Francisco Tinahones-Madueno, Carlos Clu-Fernandez, Leticia Coín-Aragüez, Juan Alcaide-Torres, Laura Mora-Navas, Isabel Cornejo-Pareja, Isabel Mancha-Doblas, Cristina Diaz-Perdigones
Publikováno v:
Endocrine Abstracts.
Autor:
Rosa M. Mateos, Carmen Segundo, Celeste Rosendo, Manuel Aguilar-Diosdado, Cristina López-Tinoco, M. Mar Roca-Rodriguez, Francisco Visiedo
Publikováno v:
Endocrine Abstracts.
Autor:
Maria Victoria Garcia-Palacios, Francisco Tinahones-Madueno, Álvaro Fernández-Deudero, M. Amor García-Valero, Mora Murri, Manuel Aguilar-Diosdado, Cristina López-Tinoco, M. Mar Roca-Rodriguez
Publikováno v:
Diabetes/Metabolism Research and Reviews. 28:542-548
Background Gestational diabetes mellitus (GDM) has been recognized as a significant risk factor for metabolic syndrome and CVD. The aim of the study was to evaluate the relationships between levels of cytokines, components of metabolic syndrome and c
Autor:
M. Mar Roca-Rodriguez, Francisco J. Tinahones, Isabel Cornejo-Pareja, Ana María Gómez-Pérez, Cristina Diaz-Perdigones, Isabel Mancha-Doblas, María Molina-Vega, M Jose Picon-Cesar, Gabriel Olveira-Fuster
Publikováno v:
Endocrine Abstracts.
Autor:
M. Mar Roca-Rodríguez, María Teresa Muros de Fuentes, Gonzalo Piédrola-Maroto, Miguel Quesada-Charneco, Silvia Maraver-Selfa, Francisco J. Tinahones, Isabel Mancha-Doblas
Publikováno v:
Atención Primaria, Vol 49, Iss 5, Pp 294-299 (2017)
Objetivo: Evaluar la tolerancia a lixisenatida y sus efectos sobre el peso y el control metabólico de pacientes con diabetes tipo 2 y obesidad. Diseño: Estudio prospectivo. Emplazamiento: Consultas de atención especializada de Endocrinología y Nu
Externí odkaz:
https://doaj.org/article/fe5c5eff125e405ca3a52694627e3bbb
Autor:
Silvia Maraver-Selfa, Francisco J. Tinahones, Isabel Mancha-Doblas, Miguel Quesada-Charneco, M. Mar Roca-Rodriguez, María Teresa Muros de Fuentes, Gonzalo Piedrola-Maroto
Publikováno v:
Atención Primaria, Vol 49, Iss 5, Pp 294-299 (2017)
To evaluate tolerance to lixisenatide and its effects on weight and metabolic control in type2 diabetes and obese patients. DESIGN: Prospective study. SETTING: Endocrinology clinics in Almeria, Granada and Malaga. PARTICIPANTS: Patients with type2 di